Copy of Newspaper Publication of Financial Results for the quarter ended June 30, 2026.

August 12, 2026 To, To, Listing/Compliance Department Listing/Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, Dalal Street, G-Block, Bandra-Kurla Complex, Mumbai – 400001 Bandra (E), Mumbai – 400051 BSE CODE – 543998 NSE Symbol: VALIANTLAB Dear Sir/Madam, Subject: Newspaper Publication of Financial Results for the Quarter ended June 30, 2026. Ref: Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Please find enclosed herewith copies of the newspaper publication of the Standalone and Consolidated Audited Financial Results for the quarter ended June 30, 2026, published in below mentioned newspapers: 1) Financial Express (in English) on August 12, 2026. 2) Mumbai Lakshadeep (in Marathi) on August 12, 2026. This intimation is also being uploaded on the Company’s website at www.valiantlabs.in We request you to take the same on record. Thanking you, Yours faithfully, For Valiant Laboratories Limited Akshay Gangurde Company Secretary & Compliance Officer Encl: As above www.valiantlabs.in | CIN : L24299MH2021PLC365904 Registered Office: 104, Udyog Kshetra, Mulund-Goregaon Link Road, Mulund (W), Mumbai - 400080. T: 022-49717221/49712001/49717220 | E: investor@valiantlabs.in WWWNANCIALEXPRESS.COM WEDNESDAY, AUGUST 12, 202¢ FINANCIAL EXPRESS 35 .. VALIANT LABORATORIES LIMITED o CIN: L24299MH2021PLC365904 Registered Office: 104, Udyog Kshetra, Mulund-Goregaon Link Road, Mulund (W), Mumbai - 400080 | Tel No.: 022-49712001 / 49717220 /49717221 Email: inveslor@valiantiabs.in ; Website: www.valiantabs.in TATEMENT OF STANDALONE AND CONSOLIDATED AUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 3 Standalone | Consolidated s Quarter Ended Year Ended Quarter Ended Year Endec] e Particulars 306026 31032026 30062025 31032026 005207 | 3032028 | 0062025 |3 13200 fudied) | (Audited) (Audited) | [Audited) | (Audited | (Aucited) | {Audted) | (Audbed) 1.| Total Income from Operations (Net) 742737 | 680761 6,167.85 2100373 |11,614.53 | 0,296.30 | 4,747.81 [20.97479 2. Net Profit! (Loss) for the period before Tax | 127280 47348 24457 15479 | 2.619.05 104.68 24481 76.82 3.| Exceptional itams - - - - - a . E 4, | Net Profit/ {Loss) for the period after Tax 94788 35328 18156 §54.82 | 2,110.30 175.87 182,08 | (32679) 5. Total Comprehensive income for the period (Comprising Profit/ (Loss) and Other Comprehansive income for the period) 94768 35203 18156 55439 | 2,10.30 176.07 162,08 | (32637) 6. Paid-up Equity Share Capital 543125 | 543125 434500 | 543125 | 543125 | 543126 | 4,345.00 | 5431.25 7. Reserve excluding Revaluation Reserves s per Balance Sheet of pravicus Accounting Year - - - 2654462 - - - | 25,657.26 8.| Earning per share (in 7) (a) Basic 175 070 042 110 389 035 0.42 (065) (b) Ciluted 175 070 042 1.10 383 0.35 0.42 (065) Notes: 1) The above s anextract of detaded format of Financial Results fled with Stock Exchanges uader Regulaticn 33of the SEBI (Ustine Oblgations and Cisclosure Requirements) Regalations, 2015, The full format of the Financial Resuits ae avaliaie on the websiteosf the Stock Exchange(s), viz., www bsendia com 2% Wi, nseindia.com znd websiie of he Company on wuw.vallamabs.in 2) The abova Financial Results br the quartar anded June 30, 2006 have baan raviewad by the Audit Committee and appmived by the Baard of Disectors inthair meeting held on Aug.st 10, 2026, 3) The Fmanuial Resulis have baen preparedin accordance with Indian Accounting Standards ("ndAS") prescribed under Section 133 of the Companies Act. 2013 read with relevant rules hiereunder andin termsof Reguiation 30 ofthe SEB! (Lising Obligatiors and Discloswre Requirements) Regulations, 2015 For Valiant Laboratories Limited Sd/- Santosh Vora Date: 10.08.2026 Managing Director Place: Mumbai DIN: 07633923 | Terare. 2. 93 HfTeE 2028 st merdn (D S et %%rqzaafizfiw%fi%g HIATATATA L4 I LUHTH? 0 7 YHIUSTHI38% 20% wTaterE: ’D(.mmvmm fimws.ggsvfiqw ¥000¢0. = R ey i e = = = = wfer 30052 | 39.03.3¢ [30.05.24 [39.03.2% [Io.0g.2¢] 3v.03.2¢] 300624 [19.03.2¢ S [TT v () 742737 | 660761 | 516785 (2199373 [11,61453 | 921530 | 4747.81 (2397678 2 | et e s /() 127280 | 47348 24457 | 75479 | 261905 | 10468 [ 244587 76.82 | e TR S () 94788 | 35328 18156 | 55482 [ 211030 [ 17587 | 18209 | (326.79) (i e v/ (o) () s e e e ()) 94788 | 35203 18156 [ 55439 | 211030 [ 17607 | 18209 | (326.37) < | S et e S 5431.25 | 543125 | 434500 [ 543125 [5431.25 [ 543125 | 434500 | 543125 5 | =i croep 5 e S e e B - & =) - - - | 26,544 62 - - - | 25,657 26 = = -175 0.70 042 1.10 389 035 04z | (0868) = -1.75 0.70 042 1.10 3.89 035 042 | (065 < (S Sy S S o) e 2084 = o 23 e S e e e Ty e e S e ee, et Pt T v e TR T WWW.BSEINGIA.COM = WIWW.NSEINa.COM s S=mfreer WM Valiantiabs in s St ot 2ost T e e s e s T e T s S 0 0L 2038 T S e e S i § e e e S e e et e rm s e S e e e e iy e S e 20= 9Frey 33 s ffer STetoe P Sreri st (egT) T T S s